Gargiulo, P. et al. Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores. Ther. Adv. Med Oncol. 11, 175883591881835 (2019).

Article  Google Scholar 

Cuffari, L., Tesseroli de Siqueira, J. T., Nemr, K. & Rapaport, A. Pain complaint as the first symptom of oral cancer: a descriptive study. Oral. Surg. Oral. Med Oral. Pathol. Oral. Radio. Endod. 102, 56–61 (2006).

Article  Google Scholar 

Carrillo, J. F., Carrillo, L. C., Ramirez-Ortega, M. C., Ochoa-Carrillo, F. J. & Oñate-Ocaña, L. F. The impact of treatment on quality of life of patients with head and neck cancer and its association with prognosis. Eur. J. Surg. Oncol. 42, 1614–1621 (2016).

Article  CAS  PubMed  Google Scholar 

Ye, Y. et al. Advances in head and neck cancer pain. J. Dent. Res. 101, 1025 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baliki, M. N. & Apkarian, A. V. Nociception, pain, negative moods, and behavior selection. Neuron 87, 474–491 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taiwo, Y. O. & Levine, J. D. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience 38, 757–762 (1990).

Article  CAS  PubMed  Google Scholar 

Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F. & Varani, K. Pathological overproduction: the bad side of adenosine. Br. J. Pharm. 174, 1945–1960 (2017).

Article  CAS  Google Scholar 

Thuraiaiyah, J., Kokoti, L., Al-Karagholi, M. A. M. & Ashina, M. Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies. J. Headache Pain. 23, 1–12 (2022).

Article  Google Scholar 

Khayami, R. et al. Role of adenosine signaling in the pathogenesis of head and neck cancer. J. Cell Biochem. 119, 7905–7912 (2018).

Article  CAS  PubMed  Google Scholar 

Bagan, J., Sarrion, G. & Jimenez, Y. Oral cancer: clinical features. Oral. Oncol. 46, 414–417 (2010).

Article  PubMed  Google Scholar 

Sidders, B. et al. Adenosine signaling is prognostic for cancer outcome and has predictive utility for immunotherapeutic response. Clin. Cancer Res. 26, 2176–2187 (2020).

Article  CAS  PubMed  Google Scholar 

Jeon, S. J. et al. Activation of adenosine A2A receptor up-regulates BDNF expression in rat primary cortical neurons. Neurochem. Res. 36, 2259–2269 (2011).

Article  CAS  PubMed  Google Scholar 

Südhof, T. C. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 80, 675–690 (2013).

Article  PubMed  Google Scholar 

Cristóvão-Ferreira, S. et al. A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes. Purinergic Signal. 9, 433–449 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Sebastião, A. M., Macedo, M. P. & Ribeiro, J. A. Tonic activation of A(2A) adenosine receptors unmasks, and of A(1) receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus. Br. J. Pharm. 129, 374–380 (2000).

Article  Google Scholar 

Dixon, A. K., Widdowson, L. & Richardson, P. J. Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum. J. Neurochem. 69, 315–321 (1997).

Article  CAS  PubMed  Google Scholar 

Ribeiro, J. A. Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Eur. J. Pharm. 375, 101–113 (1999).

Article  CAS  Google Scholar 

Carruthers, A. M. et al. Adenosine A(1) receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons. Mol. Pharm. 59, 1533–1541 (2001).

Article  CAS  Google Scholar 

Zhang, Y. et al. Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies. Cell Metab. 34, 1999–2017.e10 (2022).

Article  CAS  PubMed  Google Scholar 

Kawase, T. et al. Calcitonin gene-related peptide acts as a mitogen for human Gin-1 gingival fibroblasts by activating the MAP kinase signalling pathway. J. Periodontal Res. 34, 160–168 (1999).

Article  CAS  PubMed  Google Scholar 

Jiang, Y. et al. Neuronal TRPV1-CGRP axis regulates bone defect repair through Hippo signaling pathway. Cell Signal. 109, 110779 (2023).

Article  CAS  PubMed  Google Scholar 

De Lera Ruiz, M., Lim, Y. H. & Zheng, J. Adenosine A2A receptor as a drug discovery target. J. Med Chem. 57, 3623–3650 (2014).

Article  PubMed  Google Scholar 

Lam, D. K. & Schmidt, B. L. Orofacial pain onset predicts transition to head and neck cancer. Pain 152, 1206–1209 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Fong, L. et al. Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancer. Cancer Discov. 10, 40–53 (2020).

Article  CAS  PubMed  Google Scholar 

Chiappori, A. et al. Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC. J. Clin. Oncol. 36, 9089–9089 (2018).

Article  Google Scholar 

Ma, S. R. et al. Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma. Mol. Cancer 16, 99 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Jeske, S. S. et al. Adenosine-producing regulatory B cells in head and neck cancer. Cancer Immunol. Immunother. 69, 1205–1216 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newton, H. S., Chimote, A. A., Arnold, M. J., Wise-Draper, T. M. & Conforti, L. Targeted knockdown of the adenosine A2A receptor by lipid NPs rescues the chemotaxis of head and neck cancer memory T cells. Mol. Ther. Methods Clin. Dev. 21, 133–143 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sawynok, J. & Liu, X. J. Adenosine in the spinal cord and periphery: Release and regulation of pain. Prog. Neurobiol. 69, 313–340 (2003).

Article  CAS  PubMed  Google Scholar 

Tracey, W. D. Nociception. Curr. Biol. 27, R129–R133 (2017).

Article  PubMed  Google Scholar 

Balood, M. et al. Nociceptor neurons affect cancer immunosurveillance. Nature 611, 405–412 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toda, M. et al. Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide. Proc. Natl Acad. Sci. USA 105, 13550–13555 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amit, M. et al. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature 578, 449–454 (2020).

Article  CAS  PubMed